Krystal Biotech Inc
SWB:4KB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
SWB:4KB
|
US |
|
PLC SpA
F:O29
|
IT |
|
C
|
Coles Group Ltd
OTC:CLEGF
|
AU |
|
C
|
Christian Dior SE
DUS:DIO
|
FR |
|
C
|
Cerrado Gold Corp
XTSX:CERT
|
CA |
|
Pernod Ricard SA
PAR:RI
|
FR |
|
M
|
Minth Group Ltd
HKEX:425
|
CN |
|
P
|
Prudential Financial Inc
DUS:PLL
|
US |
|
Itron Inc
NASDAQ:ITRI
|
US |
|
C
|
Canfor Corp
SWB:NKC
|
CA |
|
B
|
Best Buy Co Inc
XMUN:BUY
|
US |
|
M
|
Microsoft Corp
BMV:MSFT
|
US |
|
Unilever Indonesia Tbk PT
F:UTG
|
ID |
|
A
|
Azimut Holding SpA
XBER:HDB
|
IT |
|
D
|
Diamondrock Hospitality Co
F:HBO
|
US |
|
Monster Beverage Corp
NASDAQ:MNST
|
US |
|
Credit Agricole SA
MIL:ACA
|
FR |
|
S
|
Schnitzer Steel Industries Inc
F:SS1A
|
US |
Wall St Price Targets
4KB Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for 4KB is 299.59 EUR with a low forecast of 188.87 EUR and a high forecast of 368.04 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4KB's stock price target?
Price Target
299.59
EUR
According to Wall Street analysts, the average 1-year price target for 4KB is 299.59 EUR with a low forecast of 188.87 EUR and a high forecast of 368.04 EUR.
What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Revenue over the next 8 years is 22%.
What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%
The compound annual growth rate for Gross Profit over the next 8 years is 22%.
What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 8 years is 31%.
What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.
What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%
The compound annual growth rate for Net Income over the next 8 years is 21%.
